CHAMPIONS ONCOLOGY, INC. Earnings Per Share, Basic and Diluted
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Earnings Per Share, Basic and Diluted of -$0.13 per share for the 12-month period ending 2018-04-30, per its 10-K filed 2018-07-30.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2018-07-30
- CHAMPIONS ONCOLOGY, INC. earnings per share, basic and diluted for the quarter ending 2018-01-31 was -$0.01.
- CHAMPIONS ONCOLOGY, INC. earnings per share, basic and diluted for the quarter ending 2017-10-31 was -$0.01.
- CHAMPIONS ONCOLOGY, INC. earnings per share, basic and diluted for the quarter ending 2017-07-31 was -$0.06.
- CHAMPIONS ONCOLOGY, INC. earnings per share, basic and diluted for the quarter ending 2017-01-31 was -$0.13.
- CHAMPIONS ONCOLOGY, INC. earnings per share, basic and diluted for fiscal 2018 was -$0.13.
- CHAMPIONS ONCOLOGY, INC. earnings per share, basic and diluted for fiscal 2017 was -$0.64.
- CHAMPIONS ONCOLOGY, INC. earnings per share, basic and diluted for fiscal 2016 was -$1.20.
- CHAMPIONS ONCOLOGY, INC. earnings per share, basic and diluted for fiscal 2015 was -$2.20.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|
| 2018-04-30 | -$0.13 10-K · filed 2018-07-30 | ||||
| 2018-01-31 | -$0.01 10-Q · filed 2018-03-19 | -$0.08 10-Q · filed 2018-03-19 | |||
| 2017-10-31 | -$0.01 10-Q · filed 2017-12-15 | -$0.07 10-Q · filed 2017-12-15 | |||
| 2017-07-31 | -$0.06 10-Q · filed 2017-09-14 | ||||
| 2017-04-30 | -$0.64 10-K · filed 2018-07-30 | ||||
| 2017-01-31 | -$0.13 10-Q · filed 2018-03-19 | -$0.44 10-Q · filed 2018-03-19 | |||
| 2016-10-31 | -$0.05 10-Q · filed 2017-12-15 | -$0.32 10-Q · filed 2017-12-15 | |||
| 2016-07-31 | -$0.26 10-Q · filed 2017-09-14 | ||||
| 2016-04-30 | -$1.20 10-K · filed 2017-07-28 | ||||
| 2016-01-31 | -$0.28 10-Q · filed 2017-03-17 | -$0.90 10-Q · filed 2017-03-17 | |||
| 2015-10-31 | -$0.29 10-Q · filed 2016-12-14 | -$0.63 10-Q · filed 2016-12-14 | |||
| 2015-07-31 | -$0.33 10-Q · filed 2016-09-14 | ||||
| 2015-04-30 | -$2.20 10-K · filed 2016-07-29 | -$0.18 10-K · filed 2015-07-29 | |||
| 2014-07-31 | -$0.05 10-Q · filed 2014-09-12 | ||||
| 2014-04-30 | -$0.11 10-K · filed 2015-07-29 | ||||
| 2014-01-31 | -$0.01 10-Q · filed 2014-03-14 | -$0.08 10-Q · filed 2014-03-14 | |||
| 2013-10-31 | -$0.03 10-Q · filed 2013-12-13 | -$0.07 10-Q · filed 2013-12-13 | |||
| 2013-07-31 | -$0.03 10-Q · filed 2014-09-12 | ||||
| 2013-04-30 | -$0.12 10-K · filed 2014-07-28 | ||||
| 2013-01-31 | -$0.02 10-Q · filed 2014-03-14 | -$0.09 10-Q · filed 2014-03-14 | |||
| 2012-10-31 | -$0.04 10-Q · filed 2013-12-13 | -$0.07 10-Q · filed 2013-12-13 | |||
| 2012-07-31 | -$0.03 10-Q · filed 2013-09-13 | ||||
| 2012-04-30 | -$0.19 10-K · filed 2013-07-26 | ||||
| 2012-01-31 | -$0.04 10-Q · filed 2013-03-13 | -$0.13 10-Q · filed 2013-03-13 | |||
| 2011-10-31 | -$0.05 10-Q · filed 2012-12-13 | -$0.09 10-Q · filed 2012-12-13 | |||
| 2011-07-31 | -$0.04 10-Q · filed 2012-09-12 | ||||
| 2011-04-30 | -$0.11 10-K · filed 2012-07-18 | ||||
| 2011-01-31 | -$0.01 10-Q · filed 2012-03-14 | -$0.03 10-Q · filed 2012-03-14 | |||
| 2010-10-31 | $0.00 10-Q · filed 2011-12-14 | -$0.02 10-Q · filed 2011-12-14 | |||
| 2010-07-31 | -$0.02 10-Q · filed 2011-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |